Cargando…

Downregulation of Immunosuppressive Environment in Patients with Chronic HBV Hepatitis on Maintained Remission

Detalles Bibliográficos
Autores principales:	Chaudhary, Belal, Elkord, Eyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324156/ https://www.ncbi.nlm.nih.gov/pubmed/25717327 http://dx.doi.org/10.3389/fimmu.2015.00052

Ejemplares similares

Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation
por: Germanidis, Georgios, et al.
Publicado: (2013)

Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
por: Elkord, Eyad, et al.
Publicado: (2015)

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
por: Chaudhary, Belal, et al.
Publicado: (2016)

Intratumoral FoxP3(+)Helios(+) Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2017)

Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells
por: Elkord, Eyad
Publicado: (2014)

Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(−) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans
por: Elkord, Eyad
Publicado: (2016)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection
por: Zhang, Lu, et al.
Publicado: (2023)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients
por: Samid, May Abd Al, et al.
Publicado: (2016)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients
por: Toor, Salman M., et al.
Publicado: (2019)

Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues
por: Srivastava, Mayank, et al.
Publicado: (2022)

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
por: Toor, Salman M., et al.
Publicado: (2016)

The Multiple Functions of B Cells in Chronic HBV Infection
por: Cai, Ying, et al.
Publicado: (2020)

Prospects for NK-based immunotherapy of chronic HBV infection
por: Jin, Xiaomeng, et al.
Publicado: (2022)

Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
por: Paquissi, Feliciano Chanana
Publicado: (2017)

CD4(+) T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model
por: Wu, Tingxin, et al.
Publicado: (2019)

Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection
por: Song, Aixin, et al.
Publicado: (2022)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
por: Ferrando-Martinez, Sara, et al.
Publicado: (2021)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
por: Hoogeveen, Ruben C., et al.
Publicado: (2020)

Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis
por: Moradi, Luke A., et al.
Publicado: (2021)

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

rt269I Type of Hepatitis B Virus (HBV) Leads to HBV e Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections
por: Lee, So-Young, et al.
Publicado: (2019)

A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine
por: Choi, Yu-Min, et al.
Publicado: (2023)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

IFNα subtype-specific susceptibility of HBV in the course of chronic infection
por: Xie, Xiaohong, et al.
Publicado: (2022)

Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment
por: Wang, Qin, et al.
Publicado: (2018)

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy
por: Pan, Shida, et al.
Publicado: (2022)

Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches
por: Fisicaro, Paola, et al.
Publicado: (2020)

An Immunosuppressive Tick Salivary Gland Protein DsCystatin Interferes With Toll-Like Receptor Signaling by Downregulating TRAF6
por: Sun, Ta, et al.
Publicado: (2018)

Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
por: Hughes, Amy, et al.
Publicado: (2017)

Management of HBV Infection During Immunosuppressive Treatment
por: Marzano, Alfredo
Publicado: (2009)

Immunosuppression in Patients with Chronic Hepatitis B
por: Seetharam, Anil, et al.
Publicado: (2014)

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
por: Khaja, Azharuddin Sajid Syed, et al.
Publicado: (2017)

Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
por: Hawkins, Russell B., et al.
Publicado: (2018)

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression
por: Tyc, Olaf, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_80hjnt4skmvqckj8crq78vcr51